MedTrace Logo

CSD170501: Study to Assess Biomarkers of Tobacco Exposure in Smokers During In-Clinic Confinement Switch to an Electronic Cigarette

NCT03170674 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2017-09-08

No results posted yet for this study

Summary

The purpose of this clinical study is to evaluate changes in biomarkers of exposure (BOE) to tobacco smoke constituents after smokers switch from combustible cigarettes to use of one of the three electronic cigarettes or abstinence.

Conditions

  • Smoking

Interventions

OTHER

FT21039

an electronic cigarette product

OTHER

FT21092

an electronic cigarette product

OTHER

FT21018

an electronic cigarette product

Sponsors & Collaborators

  • Vince & Associates Clinical Research, Inc.

    collaborator OTHER

  • RAI Services Company

    lead INDUSTRY

Principal Investigators

  • Debra Kelsh, MD · Vince & Associates Clinical Research, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2017-08-18
Completion
2017-08-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03170674 on ClinicalTrials.gov